Page last updated: 2024-09-04

butylscopolammonium bromide and Irritable Bowel Syndrome

butylscopolammonium bromide has been researched along with Irritable Bowel Syndrome in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Belcaro, G; Cacchio, M; Corsi, M; Cotellese, R; Feragalli, B; Gizzi, G; Pellegrini, L	1
Dzhanayev, YA; Golovenko, OV; Khalif, IL; Makarchuk, PA; Podmarenkova, LF; Quigley, EM	1
Evangelista, S	1
Makarchuk, PA	1

Reviews

1 review(s) available for butylscopolammonium bromide and Irritable Bowel Syndrome

Article	Year
Quaternary ammonium derivatives as spasmolytics for irritable bowel syndrome. Current pharmaceutical design, 2004, Volume: 10, Issue:28 Topics: Butylscopolammonium Bromide; Clinical Trials as Topic; Humans; Irritable Bowel Syndrome; Morpholines; Parasympatholytics; Quaternary Ammonium Compounds; Scopolamine Derivatives; Structure-Activity Relationship	2004

Trials

2 trial(s) available for butylscopolammonium bromide and Irritable Bowel Syndrome

Article	Year
Interactions between symptoms and motor and visceral sensory responses of irritable bowel syndrome patients to spasmolytics (antispasmodics). Journal of gastrointestinal and liver diseases : JGLD, 2009, Volume: 18, Issue:1 Topics: Administration, Oral; Administration, Rectal; Adult; Butylscopolammonium Bromide; Calcium Gluconate; Calendula; Colon, Sigmoid; Diarrhea; Female; Gastrointestinal Motility; Humans; Irritable Bowel Syndrome; Male; Motor Neurons; Pain; Pain Measurement; Papaverine; Parasympatholytics; Plant Preparations; Rectum; Sensory Receptor Cells; Severity of Illness Index; Suppositories; Tablets; Treatment Outcome; Young Adult	2009
[Dynamics of indices of visceral sensitivity in patients with irritable bowel syndrome treated with spasmolytics]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2007, Issue:6 Topics: Abdominal Pain; Adult; Butylscopolammonium Bromide; Female; Humans; Hyperalgesia; Irritable Bowel Syndrome; Male; Pain Measurement; Pain Threshold; Papaverine; Parasympatholytics; Surveys and Questionnaires; Treatment Outcome; Viscera	2007

Article

Year

Interactions between symptoms and motor and visceral sensory responses of irritable bowel syndrome patients to spasmolytics (antispasmodics).

Journal of gastrointestinal and liver diseases : JGLD, 2009, Volume: 18, Issue:1

Topics: Administration, Oral; Administration, Rectal; Adult; Butylscopolammonium Bromide; Calcium Gluconate; Calendula; Colon, Sigmoid; Diarrhea; Female; Gastrointestinal Motility; Humans; Irritable Bowel Syndrome; Male; Motor Neurons; Pain; Pain Measurement; Papaverine; Parasympatholytics; Plant Preparations; Rectum; Sensory Receptor Cells; Severity of Illness Index; Suppositories; Tablets; Treatment Outcome; Young Adult

2009

[Dynamics of indices of visceral sensitivity in patients with irritable bowel syndrome treated with spasmolytics].

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2007, Issue:6

Topics: Abdominal Pain; Adult; Butylscopolammonium Bromide; Female; Humans; Hyperalgesia; Irritable Bowel Syndrome; Male; Pain Measurement; Pain Threshold; Papaverine; Parasympatholytics; Surveys and Questionnaires; Treatment Outcome; Viscera

2007

Other Studies

1 other study(ies) available for butylscopolammonium bromide and Irritable Bowel Syndrome

Article	Year
Pycnogenol® supplementation improves the control of irritable bowel syndrome symptoms. Panminerva medica, 2018, Volume: 60, Issue:2 Topics: Abdomen; Adult; Butylscopolammonium Bromide; Dietary Supplements; Female; Flavonoids; Healthy Volunteers; Humans; Irritable Bowel Syndrome; Male; Middle Aged; Oxidative Stress; Pain; Parasympatholytics; Pilot Projects; Plant Extracts; Pressure; Registries	2018